Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 40th (Interim) Meeting of the 10th Board of Supervisors
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 42nd (Interim) Meeting of the 10th Board of Directors
Hubei Guangji Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Technology Group Co., Ltd. on matters relating to the repurchase and cancellation of some restricted stocks under the 2021 Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical: Announcement on the proposed guarantee for the holding subsidiary Guangji Pharmaceutical (Mengzhou) Co., Ltd.
Hubei Guangji Pharmaceutical: 000952 Guangji Pharmaceutical Investor Relations Management Information 20240516
Hubei Guangji Pharmaceutical: Notice of abnormal fluctuations in stock trading
Hubei Guangji Pharmaceutical: Announcement on holding results briefings for the first quarter of 2023 and 2024
Hubei Guangji Pharmaceutical: Report on the evaluation report on the performance of accounting firms in 2023 and the report on the performance of supervisory duties by the Audit Committee
Hubei Guangji Pharmaceutical: Annual Verification Report on the Use of Raised Funds
Hubei Guangji Pharmaceutical: Announcement of Supervisory Board Resolutions
Hubei Guangji Pharmaceutical: Guotai Junan Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Hubei Guangji Pharmaceutical Co., Ltd. in 2023
Hubei Guangji Pharmaceutical: Announcement on the proposed change of accounting firm
Hubei Guangji Pharmaceutical: 2023 Social Responsibility Report
Hubei Guangji Pharmaceutical: 2023 Independent Director Debriefing Report (Hong Kui)
Hubei Guangji Pharmaceutical: Report on the work of the Board of Supervisors for the year 2023
Hubei Guangji Pharmaceutical: Business Income Deduction Status Special Audit Report Daxin Special Review Text [2024] No. 2-00146
Hubei Guangji Pharmaceutical: Announcement of Board Resolutions
Hubei Guangji Pharmaceutical: Annual special audit report on the expenditure of related parties' funds
Hubei Guangji Pharmaceutical: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Hubei Guangji Pharmaceutical: 2023 Board Work Report
No Data